NCT06880510 · ACTIVE NOT RECRUITING

The Locus Coeruleus, Norepinephrine and Cognitive Aging

This trial is studying the locus coeruleus, a small brain region that loses health early in Alzheimer's disease. Researchers are using MRI scans, pupil-response measurements, and a mild nerve-stimulation device worn on the ear to see how this brain region functions and whether simple physical signals can reflect its condition. This is a Phase NA study, meaning it is exploratory research rather than a test of a treatment.

You may qualify if

  • 18+ years of age
  • Able to speak and understand English
  • Hearing and vision correctable to normal or near-normal
  • Willing and able to use a touchscreen
  • Willing and able to use a keyboard and mouse
  • Willing and able to undergo a MRI scan at the Cornell MRI Facility lasting approximately 90 minutes.

You're excluded if

  • Moderate or severe brain injury
  • Serious neurological disorders such as epilepsy
  • Recent concussion
  • Colorblindness
  • Use of street drugs
  • Cardiac arrhythmias

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-05-06

View full record on ClinicalTrials.gov

All APOE4 clinical trials